Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vera Therapeutics Inc Cl A (NQ: VERA ) 44.65 -1.01 (-2.22%) Streaming Delayed Price Updated: 12:50 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 177,645 Open 46.12 Bid (Size) 44.60 (1) Ask (Size) 44.70 (2) Prev. Close 45.66 Today's Range 44.47 - 46.12 52wk Range 9.240 - 50.78 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024 September 16, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN September 12, 2024 From Vera Therapeutics Via GlobeNewswire Performance YTD +186.00% +186.00% 1 Month +18.58% +18.58% 3 Month +28.81% +28.81% 6 Month +3.54% +3.54% 1 Year +196.64% +196.64% More News Read More Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 10, 2024 From Vera Therapeutics Via GlobeNewswire Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday September 03, 2024 Via Benzinga Vera Therapeutics to Participate at September Investor Conferences August 29, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 09, 2024 From Vera Therapeutics Via GlobeNewswire VERA Stock Earnings: Vera Therapeutics Misses EPS for Q2 2024 August 08, 2024 Via InvestorPlace Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results August 08, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer July 01, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Appoints Christy J. Oliger to Board of Directors June 11, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 07, 2024 From Vera Therapeutics Via GlobeNewswire Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market May 31, 2024 Via Benzinga Topics Economy Exposures Interest Rates Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker May 29, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) May 28, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress May 25, 2024 From Vera Therapeutics Via GlobeNewswire VERA Stock Earnings: Vera Therapeutics Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results May 09, 2024 From Vera Therapeutics Via GlobeNewswire Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 07, 2024 From Vera Therapeutics Via GlobeNewswire Could This Stock Be the Next Biotech Buyout? April 13, 2024 Via The Motley Fool Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact April 11, 2024 Via Benzinga Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options April 11, 2024 Via Investor's Business Daily Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 11, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
